HBAN vs NEPH · P/E 13, rev $1.56B vs P/E 48, rev $11.2M
Huntington Bancshares Incorporated (HBAN) versus Nephros Inc (NEPH) — a side-by-side from cached financials, not a winner call.
Huntington Bancshares Incorporated (HBAN) is a banks - regional company listed on US.
Nephros Inc (NEPH) is a medical instruments & supplies company listed on US.
Latest reported HBAN revenue for 2025-12-31 was $1.56B. Net income was $2.21B. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. HBAN currently screens at market cap $25.55B and trailing P/E 13.5.
Latest reported NEPH revenue for 2026-06-30 was $11.2M. Net income was $1.3M. NEPH currently screens at market cap $40.9M and trailing P/E 48.3.
HBAN currently screens at market cap $25.55B and trailing P/E 13.5. NEPH currently screens at market cap $40.9M and trailing P/E 48.3.
Not investment advice. Open the HBAN and NEPH stock pages for the full models.
Not investment advice.